Joanne A Harrold Selected Research

Joanne A Harrold Research Topics

Disease

12	Obesity 01/2012 - 10/2002
8	Weight Loss (Weight Reduction) 11/2021 - 03/2005
7	Body Weight (Weight, Body) 01/2021 - 04/2004
2	Overweight 01/2019 - 02/2008
2	Weight Gain 01/2008 - 06/2007
2	Feeding and Eating Disorders (Eating Disorder) 01/2007 - 10/2003
2	AIDS-Related Complex (ARC) 04/2004 - 03/2003
1	Alkaptonuria 05/2022
1	Cognitive Dysfunction 05/2022
1	COVID-19 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Insulin Resistance 01/2021
1	Pain (Aches) 03/2015
1	Starvation 04/2004
1	Hypoglycemia (Reactive Hypoglycemia) 04/2004
1	Hyperphagia (Overeating) 10/2002

Drug/Important Bio-Agent (IBA)

5	LeptinIBA 06/2007 - 10/2002
4	Insulin (Novolin)FDA Link 06/2007 - 10/2002
3	sibutramine (Meridia)FDA Link 01/2012 - 03/2005
3	5-HT2C Serotonin ReceptorIBA 01/2012 - 03/2005
3	lorcaserinIBA 01/2012 - 01/2007
3	Serotonin (5 Hydroxytryptamine)IBA 12/2011 - 03/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2007
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2012 - 01/2008
2	FenfluramineIBA 01/2012 - 03/2005
2	Pharmaceutical PreparationsIBA 12/2011 - 05/2010
2	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 01/2007 - 03/2005
2	LigandsIBA 01/2007 - 02/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2007 - 03/2003
2	NeuropeptidesIBA 09/2004 - 04/2004
2	CannabinoidsIBA 10/2003 - 10/2002
1	nitisinone (Orfadin)FDA Link 05/2022
1	oxidized low density lipoproteinIBA 11/2021
1	SodiumIBA 01/2021
1	3-alpha-tropyl-2-(phenylthio)butyrateIBA 01/2021
1	dapagliflozinIBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	LipidsIBA 01/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	SphingomyelinsIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	SymportersIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	TesofensineIBA 12/2011
1	Triglycerides (Triacylglycerol)IBA 02/2008
1	Nonesterified Fatty Acids (NEFA)IBA 02/2008
1	Acetates (Acetic Acid Esters)FDA Link 01/2008
1	Biomarkers (Surrogate Marker)IBA 06/2007
1	Serotonin AgentsIBA 01/2007
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 02/2006
1	Melanocortin Receptors (Melanocortin Receptor)IBA 02/2006
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2005
1	Fluoxetine (Prozac)FDA LinkGeneric 03/2005
1	melanin-concentrating hormone (melanin concentrating hormone)IBA 09/2004
1	Peptides (Polypeptides)IBA 04/2004
1	OrexinsIBA 04/2004
1	Anabolic AgentsIBA 04/2004
1	Neuropeptide YIBA 04/2004
1	alpha-MSHIBA 03/2003
1	Dimenhydrinate (DMH)FDA LinkGeneric 03/2003
1	beta-MSHIBA 03/2003
1	Guanosine 5'-O-(3-Thiotriphosphate)IBA 03/2003
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2002
1	Opioid Analgesics (Opioids)IBA 10/2002

Therapy/Procedure

3	Therapeutics 05/2022 - 01/2007
1	Caloric Restriction 11/2021
1	Perinatal Care 01/2021
1	Lasers (Laser) 03/2015
1	Drug Therapy (Chemotherapy) 01/2007